These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 18378317)

  • 1. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment.
    Katz J
    Ophthalmology; 1999 Feb; 106(2):391-5. PubMed ID: 9951496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
    Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
    Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring glaucomatous progression using a novel Heidelberg Retina Tomograph event analysis.
    Fayers T; Strouthidis NG; Garway-Heath DF
    Ophthalmology; 2007 Nov; 114(11):1973-80. PubMed ID: 17662455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.
    Kim J; Dally LG; Ederer F; Gaasterland DE; VanVeldhuisen PC; Blackwell B; Sullivan EK; Prum B; Shafranov G; Beck A; Spaeth GL;
    Ophthalmology; 2004 Nov; 111(11):2109-16. PubMed ID: 15522379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and rates of visual field progression after longitudinally measured optic disc change in glaucoma.
    Chauhan BC; Nicolela MT; Artes PH
    Ophthalmology; 2009 Nov; 116(11):2110-8. PubMed ID: 19500850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical evaluation of the diagnostic accuracy of methods used to determine the progression of visual field defects in glaucoma.
    Mayama C; Araie M; Suzuki Y; Ishida K; Yamamoto T; Kitazawa Y; Shirakashi M; Abe H; Tsukamoto H; Mishima HK; Yoshimura K; Ohashi Y
    Ophthalmology; 2004 Nov; 111(11):2117-25. PubMed ID: 15522380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study.
    Haymes SA; Hutchison DM; McCormick TA; Varma DK; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):547-54. PubMed ID: 15671281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment.
    Katz J; Congdon N; Friedman DS
    Arch Ophthalmol; 1999 Sep; 117(9):1137-42. PubMed ID: 10496384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods.
    Nouri-Mahdavi K; Caprioli J; Coleman AL; Hoffman D; Gaasterland D
    Arch Ophthalmol; 2005 Feb; 123(2):193-9. PubMed ID: 15710815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical comparison of pascal dynamic contour tonometry and goldmann applanation tonometry in asymmetric open-angle glaucoma.
    Sullivan-Mee M; Halverson KD; Qualls C
    J Glaucoma; 2007 Dec; 16(8):694-9. PubMed ID: 18091457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma.
    Fortune B; Demirel S; Zhang X; Hood DC; Patterson E; Jamil A; Mansberger SL; Cioffi GA; Johnson CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1173-80. PubMed ID: 17325161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic capability of optical coherence tomography (Stratus OCT 3) in early glaucoma.
    Parikh RS; Parikh S; Sekhar GC; Kumar RS; Prabakaran S; Babu JG; Thomas R
    Ophthalmology; 2007 Dec; 114(12):2238-43. PubMed ID: 17561260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
    Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual field loss from primary angle-closure glaucoma: a comparative study of symptomatic and asymptomatic disease.
    Ang LP; Aung T; Chua WH; Yip LW; Chew PT
    Ophthalmology; 2004 Sep; 111(9):1636-40. PubMed ID: 15350315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.